News & Sentiment
LINC Investors Have Opportunity to Lead Lincoln Educational Services Corporation Securities Fraud Lawsuit
NEW YORK, Oct. 27, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lincoln Educational Services Corporation (NASDAQ: LINC) between May 11, 2026 and August 9, 2026, inclusive (the "Class Period"), of the important November 10,...
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
153 articles
📰
Grünenthal presents Phase III results for Qutenza® in post-surgical neuropathic pain at IASP 2026 World Congress on Pain
Late-breaking data from the Phase III RISE trial further strengthen the well-established efficacy and safety profile of Qutenza®. Post-surgical...
📰
ALAMO GROUP ANNOUNCES ACQUISITION OF ECON ENGINEERING
Acquisition Expands Alamo Group's Industrial Equipment Portfolio and Strengthens the Company's Platform in the United Kingdom SEGUIN, Texas, Oct. 27,...
AMGEN TO PRESENT NEW DATA ACROSS RARE AND OTHER SERIOUS AUTOIMMUNE DISEASES AT ACR CONVERGENCE 2026
Phase 3 OASIZ-301 Study of Dazodalibep in Sjögren's Disease Shows Statistically Significant and Clinically Meaningful Improvement in Systemic Disease...
Real-World Data from OneOncology Practices Show Tarlatamab Can Be Administered Safely in the Outpatient Community Oncology Setting
Analysis of 90 patients with small cell lung cancer found mostly low-grade cytokine release syndrome and neurotoxicity across outpatient, inpatient,...
P1 PRATIA ONCOLOGY EXPANDS INTO EUROPE WITH OC ESPAÑA'S MADRID RESEARCH SITE
SEATTLE, Oct. 27, 2026 /PRNewswire/ -- P1 Pratia Oncology, a leading community-based oncology research network focused on early-phase clinical...
📰
US WorldMeds Acquires Orbus Therapeutics, Expanding Commitment to Rare Diseases and Advancing Eflornithine in Adult Malignant Glioma
Acquisition builds on Phase 3 STELLAR study results showing clinically meaningful improvements in overall and progression-free survival in the...
📰
Searchbloom Named 2026 Search Engine Land Awards "Best Commerce Search Marketing Initiative - SEO" Winner
Internationally-recognized program honors digital marketing excellence among the world's top search marketers. SOUTH JORDAN, Utah, Oct. 27, 2026...
AcuraStem Receives Hoffman ALS Clinical Trial Award to Support Phase 1 Trial of AS-241, the Clinical Candidate of its UNC13A Program
The ALS Association's $1 Million Award Will Fund Biomarker Development to Support First-in-Human Testing of AcuraStem's Lead ALS Therapy PASADENA,...
ECOVACS WINBOT W3 OMNI incluido en la lista de las Mejores Invenciones de 2026 de TIME
NUEVA YORK, 27 de octubre de 2026 /PRNewswire/ -- ECOVACS ROBOTICS, líder mundial en robótica para el hogar, tiene el honor de anunciar que su modelo...
Nyra Medical Strengthens Clinical and Market Development Leadership as CARLEN Advances into Next Phase of Clinical Evaluation
Suzanne Wallace appointed Vice President of Clinical and Market Development; Scott Tyler appointed Senior Director of Clinical Engineering and...
Post-Quantum Cryptography Market worth $3.80 billion by 2031 - Report by MarketsandMarkets™
DELRAY BEACH, Fla., Oct. 27, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Post-Quantum Cryptography Market is projected to grow from USD...
CellsBin Receives National Cancer Institute Award to Advance Blood Test for Multiple Myeloma
Study will test whether living myeloma cells can be found and recovered from a blood sample, with the goal of giving doctors bone marrow-level...
US Consumer Confidence Increased in October
Confidence revived to June levels as consumer appraisals of both the present situation and expectations for the future improved NEW YORK, Oct. 27,...
3D Cloud and MillerKnoll Bring Product Configurators to Knoll.com
An enterprise 3D content strategy helps MillerKnoll scale digital experiences, present its catalog of iconic designs consistently across brands and...
Capitainer Initiates Clinical Sampling for HbA1c FDA 510(k) Study
STOCKHOLM, Oct. 27, 2026 /PRNewswire/ -- Capitainer, a Swedish provider of volumetric microsampling solutions, has reached an important milestone in...
Registrational Phase III CLARIFY trial: Target number of participants achieved
SYDNEY, Oct. 27, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with...
Modal Raises $750 Million in Series D Round: NYSE Content Update
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Oct. 27, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE)...
📰
VolitionRx Signs LOI with Missionpharma to explore the Development and Launch of Volition's Lateral Flow Technology for NETosis Worldwide
HENDERSON, Nev., Oct. 27, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today...
IceCure Successfully Completes First Cryoablation Treatment in Its ChoICE Post-Marketing Study for Breast Cancer Cryoablation
First patient enrolled and treated at West Cancer Center in Tennessee, USA CAESAREA, Israel, Oct. 27, 2026 /PRNewswire/ -- IceCure Medical Ltd....
Ampa Introduces Target Lock to Clinics Nationwide to Support Precise, Consistent Coil Positioning
New Ampa One feature will help clinicians keep the coil in position by automatically pausing brain stimulation when coil moves off target PALO ALTO,...
📰
Capitainer Initiates Clinical Sampling for HbA1c FDA 510(k) Study
STOCKHOLM, October 27, 2026 /PRNewswire/ -- Capitainer, a Swedish provider of volumetric microsampling solutions, has reached an important milestone...
Healthgrades Names Mount Sinai Medical Center One of America's 100 Best Hospitals for Cardiac, Stroke, and Pulmonary Care and Gastrointestinal Surgery
Ranked #1 in Florida for Gastrointestinal Surgery MIAMI BEACH, Fla., Oct. 27, 2026 /PRNewswire/ -- Recognized among America's 100 Best Hospitals (Top...
📰
Orphan Therapeutics Accelerator In-Licenses Investigational Gene Therapy Program for Ornithine Transcarbamylase Deficiency from UCL Ventures and Children's Medical Research Institute
OTXL-101, a promising therapy in development for a severe, rare pediatric metabolic condition, becomes the first pipeline program to be in-licensed...
Co-Diagnostics' Joint Venture CoSara Diagnostics Completes Clinical Study and Regulatory Submission for Point-of-Care Tuberculosis Test, Sets Stage for Commercial Launch in India
CDSCO Clearance and Commercial Launch in India Anticipated Before Year-End 2026 Study Demonstrated 97.3% Sensitivity and 96.0% Specificity Consistent...
New Indication Application for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Accepted for Review by NMPA
This is the seventh indication application for sacituzumab tirumotecan (sac-TMT) and the second application for the ADC plus IO combination regimen...
CREATE Medicines to Host Pre-Congress Workshop and Present on In Vivo CAR-T for Autoimmune Disease at APLAR 2026
CREATE will bring together leaders in cell therapy and rheumatology to discuss why in vivo CAR-T is poised to become the next standard of care for...
Vanda Pharmaceuticals Announces Positive Results from Study 3601 of NEREUS™ (tradipitant) for Prevention of GLP-1-Induced Vomiting
NEREUS™ significantly reduced semaglutide induced vomiting including frequent multi-day and extreme vomiting Key Results Any vomiting (primary) 43.0%...
ECOVACS WINBOT W3 OMNI unter den „Best Inventions of 2026“ des TIME-Magazins
NEW YORK, 27. Oktober 2026 /PRNewswire/ -- ECOVACS ROBOTICS, ein weltweit führender Anbieter im Bereich der Haushaltsrobotik, gibt mit Stolz bekannt,...
Atrium Therapeutics Doses First Patient in Corventis™, the First Interventional Clinical Trial for People Living with PRKAG2 Syndrome
-- Global Phase 1/2 trial will evaluate ATR 1072 in approximately 37 participants -- -- Initial proof of concept data expected in second half of 2027...
Carnyx Therapeutics Advances Lead Oral Sleep Candidate CNYX-005 into IND-Enabling Development
INDIANAPOLIS, Oct. 27, 2026 /PRNewswire/ -- Carnyx Therapeutics Ltd. ("Carnyx" or the "Company"), a preclinical-stage biopharmaceutical company...
📰
Henlius reports positive results from ASTRIDE U.S. bridging study for serplulimab in combination with chemotherapy for first-line treatment of patients with extensive-stage small cell lung cancer (ES-SCLC)
ASTRIDE trial for first-line ES-SCLC demonstrated favorable median overall survival in serplulimab with chemotherapy versus atezolizumab plus...
📰
Implantica announces leading U.S. surgeon participates in RefluxStop® training surgeries
VADUZ, Liechtenstein, Oct. 27, 2026 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into...
📰
Implantica announces leading U.S. surgeon participates in RefluxStop® training surgeries
VADUZ, Liechtenstein, Oct. 27, 2026 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into...
📰
Valmet to acquire leading manufacturing execution system (MES) business from Tieto to accelerate industrial transition towards autonomous operations
Valmet Oyj's press release on October 27, 2026 at 8:45 a.m. EET ESPOO, Finland, Oct. 27, 2026 /PRNewswire/ -- Valmet has entered into an agreement to...
ADSQUIRE Named 2026 PPC Agency of the Year by Search Engine Land.
Philadelphia-Based Legal PPC Agency Wins Top Paid Search Agency Honor for Campaign Delivering Approximately 8,000% ROI in One Month On $4,000 In Ad...
Essential Oils Market Size to Reach $29.52 Bn by 2031 Amid Growing Demand for Aromatherapy and Pharmaceutical Applications, Says Mordor Intelligence
HYDERABAD, India, Oct. 26, 2026 /PRNewswire/ -- According to Mordor Intelligence, the essential oils market size is estimated to increase to $20.08...
FF EAI Robotics Ecosystem (FFR) Completes Acquisition of FFAI Robotics Business, Establishing a Nasdaq-Listed Humanoid and Bionic Robotics Platform October Robot Sales Expected to Exceed 300 Units; Unveils FF OmniMind, a Unified AI Brain for All Robots
FFR has completed its acquisition of FFAI's robotics business and issued and delivered common shares and non-voting convertible preferred shares to...
📰
NOBLE CORPORATION PLC ANNOUNCES THIRD QUARTER 2026 RESULTS
Approximately $560 million in new contract value awarded since the July fleet status report; backlog stands at $6.7 billion. $0.50 per share cash...
📰
CUMBERLAND PHARMACEUTICALS ANNOUNCES PLANS TO FILE NEW DRUG APPLICATION FOR IFETROBAN DMD PROGRAM
NASHVILLE, Tenn., Oct. 26, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), ("Cumberland" or the "Company") an innovation-focused...
📰
Danaos Corporation Announces Moody's Outlook Change to Positive and Upgrade of Senior Unsecured Notes to Ba1
ATHENS, Greece, Oct. 26, 2026 /PRNewswire/ -- Danaos Corporation ("Danaos" or the "Company") (NYSE: DAC), one of the world's largest independent...
Whirlpool Corporation Announces Third-Quarter Results
Executed price increases and structural cost actions, delivering sequential operational progress in Q3 against a tough macroeconomic backdrop...
FF EAI Robotics Ecosystem Completed its Acquisition of the Robotics Business of Faraday Future, Establish Nasdaq-Listed Humanoid and Bionic Robotics Platform
FFR expects October 2026 robot sales and shipments to exceed 300 units, setting a new monthly record and bringing cumulative shipments to more than...
Mount Sinai Medical Center Physician Leads Global Phase 3 Trial Showing Chemotherapy-Free Treatment Improves Outcomes for Women with dMMR Endometrial Cancer
KEYNOTE-C93/GOG-3064/ENGOT-en15 results presented in the ESMO 2026 Presidential Symposium and published simultaneously in The Lancet MIAMI BEACH,...
📰
Nature Medicine Study of 8,000+ Women Finds Significant Weight Loss and 91% Treatment Retention With Digital GLP-1 Care
Research conducted in partnership with University College London examines personalised dosing, clinical monitoring and metabolic health outcomes in...
Next-Gen Drug Significantly Prevents Return of and Death From Endometrial Cancer
NEW YORK, Oct. 26, 2026 /PRNewswire/ -- A new drug is effective at decreasing recurrence of and death from endometrial cancer, a landmark...
GrOwnValve Achieves Primary Safety Endpoint in First-in-Human Heart Valve Study
All five patients complete six-month follow-up without predefined prosthesis-related safety events BERLIN, Oct. 26, 2026 /PRNewswire/ -- GrOwnValve...
JAK Inhibitors Market to Register Notable Growth During the Forecast Period (2026-2036) Through Expanding Clinical and Commercial Landscape | DelveInsight
The JAK inhibitors market is expected to witness steady growth, driven by the increasing prevalence of autoimmune and inflammatory diseases, growing...
📰
Innovent Announces NMPA Acceptance of a New Indication Application of Sintilimab for the Treatment of Advanced Melanoma
SAN FRANCISCO and SUZHOU, China, Oct. 26, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical...